BioSpace News Archive

Greenberg will lead PatientPoint efforts to earn Point of Care Communication Council certification in 2020

Biocom, the association representing the life science industry of California, issued the following statement in response to the revised United States-Mexico-Canada Agreement deal unveiled yesterday by the Trump Administration.

The co-chairs of the federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses—Dr. Theresa Tam, Chief Public Health Officer of Canada, and Dr. Saqib Shahab, Saskatchewan’s Chief Medical Health Officer—issued the following statement on the release of new data on opioid-related harms in Canada..

Katherine Pollard becomes director of the Biological and Medical Informatics Graduate Program at UC San Francisco

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that the European Patent Office issued European Patent No. 2968992 to the Company on December 11, 2019.

miRagen Therapeutics, Inc. announced a series of strategic changes across its business that are intended to reallocate its existing capital to deliver important milestones in 2020.

Assembly Biosciences, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Intersect ENT, Inc., announced that management will participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at the Westin St. Francis Hotel in San Francisco, and will present at 1:30 p.m. PT..

Investigational KTE-X19 To Be First Chimeric Antigen Receptor (CAR) T Cell Therapy for Mantle Cell Lymphoma if Approved

On December 2, 2019, Jubilant DraxImage Inc. and certain of its affiliates received notice of the favorable decision of the U.S. International Trade Commission in its case against Bracco Diagnostics Inc.